Three-dimensional structure of a Nanobody® (modeled on the VHH with pdb-code 1U0Q, Cambillau et al). The target molecule is recognized by the surface formed by three hypervariable regions located at the top of the molecule (in green, cyan and blue). Hallmarks, amino acid residues that further differentiate a camelid VHH from a human VH, can be located at different positions within the framework regions, and here are coloured red, pink and magenta.

Home INVESTOR RELATIONS Corporate Governance

Corporate Governance

Composition Board of Directors

 

Articles of Association

 

Corporate Governance Charter

The application of corporate governance rules at Ablynx are in line with the recommendations of the Belgian Code on Corporate Governance which came into effect as of 1 January 2005. Ablynx stands by the principles of this Code.

For further information on the Corporate Governance Code:
investors@ablynx.com

Dealing code

For further information on the Dealing Code: dealing_code@ablynx.com

 

Statutory Auditor

PricewaterhouseCoopers Bedrijfsrevisoren bcvba

Woluwe Garden

Woluwe 18

B-1932 Sint-Stevens-Woluwe

represented by

Raf Vander Stichele

Bedrijfsrevisor

Latest News


27/07/2010

ABLYNX ANNOUNCES CHANGE IN MANAGEMENT

23/07/2010

ABLYNX ANNOUNCES WARRANT EXERCISE

12/07/2010

NOVARTIS OBTAINS LICENSES TO DEVELOP AND COMMERCIALISE TWO NOVEL NANOBODIES®


Email alerts

If you would like to receive updates on the company news, please
click here